for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cardinal Health Inc

CAH

Latest Trade

52.63USD

Change

0.32(+0.61%)

Volume

2,218,797

Today's Range

51.44

 - 

52.66

52 Week Range

45.85

 - 

62.96

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
52.31
Open
52.28
Volume
2,218,797
3M AVG Volume
68.22
Today's High
52.66
Today's Low
51.44
52 Week High
62.96
52 Week Low
45.85
Shares Out (MIL)
281.79
Market Cap (MIL)
14,740.33
Forward P/E
8.90
Dividend (Yield %)
3.75

Next Event

Q2 2022 Cardinal Health Inc Earnings Release

Latest Developments

More

Cardinal Health Provides Fiscal Year 2022 Financial Update

Clarity Pharmaceuticals Says Co And Cardinal Health Enter Into Agreement For Targeted Copper Theranostics

Cardinal Health Inc- Sees Low-Double Digit Percentage Growth For Pharma Segment Revenue In FY22

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cardinal Health Inc

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.

Industry

Biotechnology & Drugs

Contact Info

7000 Cardinal Pl

DUBLIN, OH

43017-1091

United States

+1.614.7573033

https://www.cardinalhealth.com/en.html

Executive Leadership

Gregory B. Kenny

Independent Non-Executive Chairman of the Board

Michael C. Kaufmann

Chief Executive Officer, Director

Jason M. Hollar

Chief Financial Officer

Victor L. Crawford

Chief Executive Officer - Pharmaceutical Segment

Stephen M. Mason

Chief Executive Officer - Medical Segment

Key Stats

2.81 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

145.5K

2020

152.9K

2021

162.5K

2022(E)

177.8K
EPS (USD)

2019

5.280

2020

5.450

2021

5.570

2022(E)

5.431
Price To Earnings (TTM)
13.52
Price To Sales (TTM)
0.09
Price To Book (MRQ)
10.66
Price To Cash Flow (TTM)
7.65
Total Debt To Equity (MRQ)
405.89
LT Debt To Equity (MRQ)
384.28
Return on Investment (TTM)
6.65
Return on Equity (TTM)
2.68

Latest News

Latest News

Most U.S. local governments opt to join $26 billion opioid settlement

U.S. cities and counties have embraced a proposed settlement worth up to $26 billion resolving lawsuits alleging three large drug distributors and drugmaker Johnson & Johnson fueled the U.S. opioid epidemic, lawyers behind the deal said on Wednesday, increasing the odds...

Rhode Island, in reversal, to settle opioid claims against U.S. drug distributors

Rhode Island on Tuesday reversed course and threw its support behind a $21 billion nationwide settlement it originally declined to back resolving lawsuits alleging that three large drug distributors fueled the deadly U.S. opioid epidemic.

J&J reaches opioid settlement with holdout U.S. state New Mexico

Johnson & Johnson on Friday said it had agreed to pay $44 million to resolve claims that it fueled the opioid epidemic in New Mexico, a state which originally opted against participating in a nationwide settlement resolving thousands of similar cases.

In reversal, Georgia joins $26 billion U.S. opioid settlement

The state of Georgia has decided to join a proposed $26 billion nationwide settlement resolving lawsuits alleging that three large drug distributors and drugmaker Johnson & Johnson fueled the deadly U.S. opioid epidemic.

Nevada to join $26 billion opioid settlement with drug distributors, J&J

Nevada has agreed to back a proposed nationwide settlement worth up to $26 billion resolving lawsuits against three large drug distributors and the drugmaker Johnson & Johnson over the deadly U.S. opioid epidemic, the state's attorney general said on Tuesday.

U.S. drug distributors extend deadline for state subdivisions to join opioid settlement

Drug distributors McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc said on Wednesday the deadline for U.S. state subdivisions to join an opioid settlement agreement has been extended to Jan. 26 from Jan. 2.

FDA classifies recall of Cardinal Health's catheter devices as most serious

The U.S. Food and Drug Administration on Friday classified the recall of some of Cardinal Health Inc's devices, which are used to insert umbilical vein catheters in infants, as the most serious type of recall after two reports of death.

U.S. state officials urge support for landmark $26 billion opioid settlement

A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments.

Big three drug distributors blame doctors, regulators in trial over opioid epidemic

The three largest U.S. drug distributors, facing their first trial over claims that they fueled the opioid crisis, said responsibility for ballooning painkiller sales lies with doctors, drugmakers and regulators.

West Virginia city takes big three drug distributors to court over opioids

The three largest U.S. drug distributors are facing trial on Monday in West Virginia in a lawsuit accusing them of fueling the opioid crisis that has resulted in 500,000 overdose deaths in the United States over two decades.

Drug distributors lose bid to escape West Virginia opioid lawsuit

The nation's "Big Three" leading drug distributors have failed to escape a lawsuit by the city of Huntington, West Virginia, and its county seeking to hold them liable for harms caused by the opioid epidemic.

Cardinal Health to sell Cordis medical device business in $1 billion deal

Cardinal Health Inc will sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion, the drug distributor said on Friday.

Cardinal Health to sell medical device business in deal valued at $1 bln

Drug distributor Cardinal Health Inc said on Friday it would sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

BRIEF-Cardinal Health Says Dave Evans To Join Board Of Directors

* DAVE EVANS TO JOIN CARDINAL HEALTH BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Robbins Geller picked to lead investor case against Cardinal Health

Robbins Geller Rudman & Dowd has beat out two other top plaintiffs firms for the job of lead counsel in a proposed class action alleging Cardinal Health Inc misled investors about problems at a medical device maker it bought.

BRIEF-Cardinal Health Announces Redemption Of Outstanding Notes

* CARDINAL HEALTH INC - SENDING IRREVOCABLE NOTICE OF EARLY REDEMPTION TO HOLDERS OF CO'S $500 MILLION 4.625% NOTES DUE 2020

BRIEF-Cardinal Health - Sees Mid-Single Digit Percentage Decline In 2020 Pharmaceutical Segment Profit - Presentation

* CARDINAL HEALTH - SEES MID-SINGLE DIGIT PERCENTAGE DECLINE IN 2020 PHARMACEUTICAL SEGMENT PROFIT - PRESENTATION Source text for Eikon: Further company coverage:

BRIEF-Cardinal Health Reports Q3 Results For Fiscal Year 2020

* CARDINAL HEALTH REPORTS THIRD QUARTER RESULTS FOR FISCAL YEAR 2020

BRIEF-Cardinal Health - Jason Hollar Will Receive A Base Salary Of $700,000

* CARDINAL HEALTH - JASON HOLLAR WILL RECEIVE A BASE SALARY OF $700,000 Source text for Eikon: https://bit.ly/2IYvLGH Further company coverage:

BRIEF-Cardinal Health Names Jason Hollar As New Chief Financial Officer

* CARDINAL HEALTH NAMES JASON HOLLAR AS NEW CHIEF FINANCIAL OFFICER

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up